Viewing StudyNCT06492759



Ignite Creation Date: 2024-07-17 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06492759
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-09
First Post: 2024-07-01

Brief Title: High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
Sponsor: Emory University
Organization: Emory University

Organization Data

Organization: Emory University
Class: OTHER
Study ID: STUDY00005578
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Emory University
Lead Sponsor Class: OTHER
Responsible Party: Manali Bhave
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Emory University
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH